Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

9.13
Delayed Data
As of 12:39pm ET
 -0.181 / -1.94%
Today’s Change
5.82
Today|||52-Week Range
11.34
+49.17%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close9.31
Today’s open9.30
Day’s range9.01 - 9.30
Volume10,592
Average volume (3 months)56,558
Market cap$124.0M
Dividend yield--
Data as of 12:39pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)-29.85%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales142.00
Price/Book4.69

Competitors

 Today’s
change
Today’s
% change
OPHTOphthotech Corp+0.18+5.78%
BLRXBioLine RX Ltd+0.01+1.00%
CPIXCumberland Pharmaceu...-0.03-0.39%
--EcoGreen Internation...-0.02-9.36%
Data as of 12:54pm ET, 11/17/2017

Financials

Next reporting dateJanuary 31, 2018
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$641.0K
Annual profit (last year)-$11.0M
Net profit margin-1,710.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts